Diabetic Macular Edema

CHICAGO — In this Healio Video Perspective from the AAO meeting, Jay S. Duker, MD, president and CEO of EyePoint Pharmaceuticals, shares an update on Duravyu for wet age-related macular degeneration.

The European Commission has approved Opuviz 40 mg/mL solution, a biosimilar referencing Eylea, according to a press release from Samsung Bioepis and Biogen.

NEW YORK — In this Healio Video Perspective from OSN New York Retina, Rishi P. Singh, MD, FASRS, of Cleveland Clinic Florida discusses the need for anti-VEGF biosimilars and the possibility of on-label bevacizumab.

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Diana Do, MD, discusses the PHOTON extension study, which examined the effect of Eylea HD in patients with diabetic macular edema.

INDIANAPOLIS — Intravitreal aflibercept 8 mg achieved improvements in best corrected visual acuity among a diverse cohort of patients with diabetic macular edema, according to data presented at Academy 2024.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Michael W. Stewart, MD, shares his experience with Eylea HD in neovascular age-related macular degeneration and diabetic macular edema.

November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent Blindness.

In this episode of Meeting Mic, we bring you pearls and perspectives from the American Academy of Ophthalmology 2024 Meeting with a focus on AMD and retina.

EyePoint Pharmaceuticals has announced positive 16-week data from the ongoing phase 2 VERONA trial evaluating Duravyu for patients with diabetic macular edema, according to a press release.